Synaptic plasticity in early aging

Ageing Res Rev. 2006 Aug;5(3):255-80. doi: 10.1016/j.arr.2006.03.008. Epub 2006 Aug 28.


Studies of how aging affects brain plasticity have largely focused on old animals. However, deterioration of memory begins well in advance of old age in animals, including humans; the present review is concerned with the possibility that changes in synaptic plasticity, as found in the long-term potentiation (LTP) effect, are responsible for this. Recent results indicate that impairments to LTP are in fact present by early middle age in rats but only in certain dendritic domains. The search for the origins of these early aging effects necessarily involves ongoing analyses of how LTP is induced, expressed, and stabilized. Such work points to the conclusion that cellular mechanisms responsible for LTP are redundant and modulated both positively and negatively by factors released during induction of potentiation. Tests for causes of the localized failure of LTP during early aging suggest that the problem lies in excessive activity of a negative modulator. The view of LTP as having redundant and modulated substrates also suggests a number of approaches for reversing age-related losses. Particular attention will be given to the idea that induction of brain-derived neurotrophic factor, an extremely potent positive modulator, can be used to provide long periods of normal plasticity with very brief pharmacological interventions. The review concludes with a consideration of how the selective, regional deficits in LTP found in early middle age might be related to the global phenomenon of brain aging.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Aging / physiology*
  • Animals
  • Brain / drug effects
  • Brain / physiology*
  • Humans
  • Long-Term Potentiation / drug effects
  • Memory Disorders / drug therapy
  • Memory Disorders / physiopathology*
  • Neuronal Plasticity* / drug effects
  • Nootropic Agents / pharmacology
  • Nootropic Agents / therapeutic use


  • Nootropic Agents